← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Discoverybiomed, Inc.
Birmingham, AL
$11,525,880
Total funding
16
Grants
Funding over time
peak $1.4M · FY2008–21$2M$1.5M$1M$500K$0
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
Funding mix
By agency
NIH$11,525,880 · 16
By mechanism
R44$7,794,112 · 6
R43$1,843,035 · 8
R42$1,602,197 · 1
R41$286,536 · 1
Investigators at Discoverybiomed, Inc.
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
All-Time
Most funded here, all years
Largest grants
Broad Spectrum Bitter Taste Antagonists Discovery$816,655
R42 · FY2020 · DC
Adiponectin Secretion Enhancer Synthetic Organic Drug Discovery and Development$812,130
R44 · FY2015 · DK
Adiponectin Secretion Enhancer Synthetic Organic Drug Discovery and Development$799,290
R44 · FY2016 · DK
Broad Spectrum Bitter Taste Antagonists Discovery$764,602
R42 · FY2021 · DC
CF Corrector Ligands Discovered on CF Human Airway Cells$726,158
R44 · FY2011 · DK
CF Corrector Ligands Discovered on CF Human Airway Cells$651,403
R44 · FY2012 · DK
DBM Anti-Proliferative Lead Small Molecules for Polycystic Kidney Disease$631,732
R44 · FY2015 · DK
Humanized Kidney Cellular Toxicity Platforms$552,227
R44 · FY2019 · ES
Humanized Kidney Cellular Toxicity Platforms$521,625
R44 · FY2018 · ES
DBM Anti-Proliferative Lead Small Molecules for Polycystic Kidney Disease$503,386
R44 · FY2014 · DK
Genotyped and Single Cyst-derived Human ADPKD Cell Platforms for Industry and Academia$453,894
R44 · FY2017 · OD
DBM Anti-Proliferative Lead Small Molecules for Polycystic Kidney Disease$436,560
R44 · FY2013 · DK
Genotyped and Single Cyst-derived Human ADPKD Cell Platforms for Industry and Academia$384,986
R44 · FY2018 · OD
Sodium Transport Inhibitors for Hypertension and Cystic Fibrosis$373,163
R44 · FY2010 · DK
Sodium Transport Inhibitors for Hypertension and Cystic Fibrosis$373,163
R44 · FY2009 · DK
Genotyped and Single Cyst-derived Human ADPKD Cell Platforms for Industry and Academia$366,185
R44 · FY2016 · OD
Cystic Fibrosis Corrector Ligands Discovered in CF Human Airway Cells$322,000
R43 · FY2009 · DK
STING Inhibitor Discovery for Rare and Common Autoimmune Diseases$300,000
R43 · FY2019 · AI
Bitter Human Taste Bud Epithelial Cell Platforms for Bitter Taste Antagonist Discovery$271,108
R41 · FY2018 · DC
Discovery of Inhibitors of PTH-Wnt Signaling Synergy in Bone Cells$234,330
R43 · FY2010 · AR